Skip to main content
OpenTrials
Completed

NCT Number: NCT04899505

Evaluation of the Impact of Chemotherapy on Body Odor in Adolescents and Young Adults in Oncology

The appearance of unpleasant body odors in adolescent Young adult (aya) wille be evaluated undergoing chemotherapy

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Solid Tumor, Adult Chemotherapy Effect Solid Tumor, Childhood

Age range

15 year–25 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Institut Curie

Paris, 75, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged between 15 and 25 years;
  • New patients treated at the Curie Institute and hospitalized in the AJA oncology department;
  • Patient undergoing chemotherapy administered intravenously;
  • Solid tumors.

Exclusion criteria

  • Patient undergoing oral chemotherapy;
  • Persons deprived of their liberty or under guardianship (including guardianship);
  • Inability to undergo medical monitoring of the trial for geographical, social or psychological reasons.

Treatment and study plan

Evaluation on appearance of unpleasant body odors

Other

Percentage of patients reporting discomfort with unpleasant body odor that occurred during their treatment. This percentage will be calculated from the response to item Q1 of the patient questionnaire during the fourth course of chemotherapy in the AJA oncology department.

Primary outcomes

  1. Incidence of the development of unpleasant body odors in AYA oncology patients

    Time frame: 8 months

    Percentage of patients reporting discomfort with unpleasant body odor that occurred during their treatment. This percentage will be calculated from the response to item Q1 of the patient questionnaire during the fourth course of chemotherapy in the AJA oncology department

Secondary outcomes

  1. Qualification of the smell and the discomfort felt

    Time frame: 8 months

    Answers to the investigation intended for patients for the appearance of the smell with different proposals like sweating, urine, breath etc. (Q2), its qualifier with different proposals like desagreable, infective, nauseating, etc…(Q3) and the discomfort observed for themselves or for those around them (Q8)

  2. Quantification of the discomfort and the impact on quality of life

    Time frame: 8 months

    Answers to the investigation intended for patients to assess the intensity of the smell with a scale (0= no smell and 10 = strong smell) (Q4), its daily impact with a scale (0=no impact and 10= high impact) (Q7) and solutions that can reduce smell with different proposals like perfume, cream, essential oil (Q9)

  3. Identify possible causes of the appearance of these new body odors

    Time frame: 8 months

    Answers to the investigation for patients to assess the link between smell and drug treatment with different proposals like treatment, hospital's food or hospital cleaning product (Q5 and Q6)

Sponsors and collaborators

Lead sponsor

Institut Curie

Other

Registry information

Official study title

ODORAJA:Evaluation of the Impact of Chemotherapy on Body Odor in Adolescents and Young Adults in Oncology

Acronym: ODORAJA

Important dates

Study start
2021
Primary completion
2025
Study completion
2025
First posted
May 24, 2021
Registry last updated
May 16, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.